Your browser doesn't support javascript.
loading
Impact on Health-Related Quality of Life of Induction Chemotherapy Compared With Concurrent Cisplatin and Radiation Therapy in Patients With Head and Neck Cancer.
Adkins, D; Ley, J; Oppelt, P; Gay, H A; Daly, M; Paniello, R C; Jackson, R; Pipkorn, P; Rich, J; Zevallos, J; Trinkaus, K; Thorstad, W.
Afiliación
  • Adkins D; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA. Electronic address: dadkins@wustl.edu.
  • Ley J; Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Oppelt P; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Gay HA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Daly M; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Paniello RC; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Jackson R; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Pipkorn P; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Rich J; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Zevallos J; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Otolaryngology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Trinkaus K; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Thorstad W; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Clin Oncol (R Coll Radiol) ; 31(9): e123-e131, 2019 09.
Article en En | MEDLINE | ID: mdl-31147146
ABSTRACT

AIMS:

Organ preservation, an important goal in the treatment of head and neck squamous cell carcinoma (HNSCC), may include induction chemotherapy and cisplatin with radiation therapy (CRT). To our knowledge, no reports have directly compared the impact of induction chemotherapy with that of CRT on health-related quality of life (HRQOL). MATERIALS AND

METHODS:

In a phase II trial, we assessed the HRQOL of patients treated with induction chemotherapy followed by CRT. Eligible patients had stage III-IV HNSCC. HRQOL questionnaires were administered at baseline, the end of induction (EOI), the end of CRT (EOCRT) and after CRT. Functional Assessment of Cancer Therapy (FACT version 4) assessed HRQOL. We carried out a comparison of changes in HRQOL from baseline to EOI and from EOI to EOCRT. This trial is registered with ClinicalTrials.gov (NCT01566435).

RESULTS:

Thirty patients were enrolled in the study. Most HRQOL questionnaires were completed (88%). The mean total FACT scores did not differ from baseline to EOI (general 83.8 versus 79.1, P = 0.08; head and neck 109.7 versus 105.8, P = 0.33; Total Outcome Index 69.7 versus 62.3, P = 0.03; respectively, using P ≤ 0.01 to adjust for multiple simultaneous tests of differences). However, total FACT scores significantly worsened from EOI to EOCRT (79.1 versus 62.3, P = 0.01; 105.8 versus 74.2, P < 0.01; 62.3 versus 34.2, P = 0.01; respectively). Within domains, the head and neck cancer subscale score did not differ from baseline to EOI (median 28.5 versus 27.0, P = 0.69), but significantly worsened from EOI to EOCRT (27.0 versus 9.5, P < 0.01). Swallowing, oral pain and voice quality improved from baseline to EOI, but worsened from EOI to EOCRT. Physical and functional scores worsened from baseline to EOI and from EOI to EOCRT. The emotional well-being score improved from baseline to EOI but worsened from EOI to EOCRT.

CONCLUSIONS:

Overall, HRQOL did not significantly change from baseline to EOI but dramatically worsened from EOI to EOCRT.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Cisplatino / Quimioradioterapia / Quimioterapia de Inducción / Neoplasias de Cabeza y Cuello / Antineoplásicos Tipo de estudio: Qualitative_research Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Cisplatino / Quimioradioterapia / Quimioterapia de Inducción / Neoplasias de Cabeza y Cuello / Antineoplásicos Tipo de estudio: Qualitative_research Aspecto: Patient_preference Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
...